Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Ninlaro
Descriptions
Ixazomib is used in combination with lenalidomide and dexamethasone to treat multiple myeloma (a type of bone marrow cancer) in patients who have received at least one prior treatment. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Ixazomib is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.